CompletedNCT00880503

Collection of Tissue Samples for Study of Multidrug Resistance

Studying Medullary thyroid carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
William D Figg, Pharm.D., Pharm.D
National Cancer Institute (NCI)
Enrollment
325 target
Eligibility
18-99 years · All sexes
Timeline
20032018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00880503 on ClinicalTrials.gov

Other trials for Medullary thyroid carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Medullary thyroid carcinoma

← Back to all trials